Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have spe…
Biotechnology
US, Boston [HQ]
VRTX/Financial Reporting
Income Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 102.00 | 143.00 | 1,410.00 | 1,527.00 | 1,211.00 | 580.00 | 1,032.00 | 1,702.00 | 2,488.00 | 3,047.00 | 4,162.00 | 6,205.00 | 7,574.00 | 8,930.00 | 9,839.00 | |
|
EPS
|
-3.70 | -3.77 | 0.14 | -0.50 | -1.98 | -3.14 | -2.31 | -0.46 | 1.06 | 8.25 | 4.58 | 10.44 | 9.09 | 12.97 | 14.05 | |
| Diluted in mil. | -3.70 | -3.77 | 0.14 | -0.50 | -1.98 | -3.14 | -2.31 | -0.46 | 1.04 | 8.09 | 4.51 | 10.29 | 9.01 | 12.82 | 13.89 | |
|
Profit
|
87.00 | 130.00 | 1,330.00 | 1,247.00 | 1,081.00 | 519.00 | 906.00 | 1,491.00 | 2,213.00 | 2,638.00 | 3,615.00 | 5,469.00 | 6,670.00 | 7,850.00 | 8,576.00 | |
| Gross Margin | 86.08 | 91.12 | 94.29 | 81.67 | 89.25 | 89.49 | 87.84 | 87.64 | 88.95 | 86.56 | 86.84 | 88.14 | 88.06 | 87.90 | 87.17 | |
| Pre Tax | -642.00 | -754.00 | 60.00 | -12.00 | -976.00 | -734.00 | -559.00 | -67.00 | -15.00 | 600.00 | 1,394.00 | 3,116.00 | 2,730.00 | 4,232.00 | 4,379.00 | |
| Profit Margin | -629.28 | -526.35 | 4.28 | -0.81 | -80.54 | -126.61 | -54.21 | -3.96 | -0.63 | 19.70 | 33.51 | 50.22 | 36.05 | 47.39 | 44.51 | |
| ETR | -3.01 | -2.55 | 31.87 | -313.01 | 29.56 | -0.95 | -5.43 | -24.74 | 684.07 | -247.71 | 15.64 | 13.00 | 14.22 | 21.51 | 17.36 | |
| Net | -641.00 | -754.00 | 29.00 | -107.00 | -445.00 | -738.00 | -558.00 | -112.00 | 263.00 | 2,096.00 | 1,176.00 | 2,711.00 | 2,342.00 | 3,322.00 | 3,619.00 | |
| Profit Margin | -628.70 | -526.35 | 2.10 | -7.01 | -36.72 | -127.25 | -54.06 | -6.58 | 10.59 | 68.80 | 28.27 | 43.70 | 30.92 | 37.20 | 36.79 | |
| EBITDA | -542.00 | -662.00 | 221.00 | 4.00 | 504.00 | -611.00 | -473.00 | 15.00 | 311.00 | 663.00 | 1,457.00 | 3,188.00 | 2,788.00 | 4,345.00 | 3,931.00 | |
| EBITDA Margin | -531.80 | -461.86 | 15.72 | 0.27 | 41.63 | -105.28 | -45.83 | 0.90 | 12.51 | 21.76 | 35.02 | 51.37 | 36.82 | 48.65 | 39.96 | |
| Operating Income | -613.00 | -696.00 | 113.00 | 2.00 | -903.00 | -692.00 | -468.00 | 9.00 | 123.00 | 635.00 | 1,197.00 | 2,856.00 | 2,782.00 | 4,307.00 | 3,750.00 | |
| Operating Margin | -601.10 | -485.51 | 8.07 | 0.15 | -74.54 | -119.30 | -45.40 | 0.58 | 4.95 | 20.84 | 28.77 | 46.03 | 36.73 | 48.23 | 38.12 | |
| Interest Income | 5.00 | 1.00 | 1.00 | 1.00 | - - | - - | - - | - - | - - | - - | 63.00 | 22.00 | 4.00 | 144.00 | 614.00 | |
| Loss | -694.00 | -837.00 | -1,188.00 | -1,522.00 | -1,411.00 | -1,221.00 | -1,498.00 | -1,690.00 | -2,095.00 | -2,383.00 | -2,960.00 | -3,336.00 | -4,795.00 | -4,565.00 | -6,088.00 | |
| Cost of Revenue | -14.00 | -12.00 | -80.00 | -279.00 | -130.00 | -60.00 | -125.00 | -210.00 | -275.00 | -409.00 | -547.00 | -736.00 | -904.00 | -1,080.00 | -1,262.00 | |
|
Operating Expenses
|
-679.00 | -825.00 | -1,108.00 | -1,242.00 | -1,281.00 | -1,160.00 | -1,373.00 | -1,480.00 | -1,820.00 | -1,974.00 | -2,413.00 | -2,599.00 | -3,891.00 | -3,485.00 | -4,826.00 | |
| R&D | -550.00 | -637.00 | -707.00 | -806.00 | -918.00 | -855.00 | -996.00 | -1,047.00 | -1,324.00 | -1,416.00 | -1,754.00 | -1,829.00 | -3,051.00 | -2,540.00 | -3,690.00 | |
| G&A | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| SG&A | -129.00 | -187.00 | -400.00 | -436.00 | -362.00 | -305.00 | -377.00 | -432.00 | -496.00 | -557.00 | -658.00 | -770.00 | -840.00 | -944.00 | -1,136.00 | |
| S&M | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Depreciation and Amortization | -30.00 | -30.00 | -35.00 | -38.00 | -48.00 | -63.00 | -62.00 | -61.00 | -61.00 | -72.00 | -106.00 | -109.00 | -125.00 | -148.00 | -181.00 | |
| Interest Expenses | -13.00 | -19.00 | -36.00 | -14.00 | -22.00 | -72.00 | -84.00 | -81.00 | -57.00 | -34.00 | -58.00 | -58.00 | -61.00 | -54.00 | -44.00 | |
| Other Expenses | -49.00 | -42.00 | -124.00 | -1.00 | -776.00 | -20.00 | -8.00 | -2.00 | -350.00 | -29.00 | -197.00 | -260.00 | -51.00 | -75.00 | -629.00 | |
|
WA Shares Outstanding
|
173.00 | 200.00 | 204.00 | 211.00 | 224.00 | 234.00 | 240.00 | 243.00 | 248.00 | 254.00 | 256.00 | 259.00 | 257.00 | 256.00 | 257.00 | |
| Diluted | 173.00 | 200.00 | 208.00 | 211.00 | 224.00 | 235.00 | 241.00 | 244.00 | 253.00 | 259.00 | 260.00 | 263.00 | 259.00 | 259.00 | 260.00 |